All
What's New on Dermatology Times®: October 3-7
Click to see a preview of what to expect this week.
The Weekly Roundup: September 26-30
ICYMI, this week we had stories about new study data on roflumilast foam for scalp and body psoriasis, dupilumab's FDA approval, the future of basal cell carcinoma treatment, and more.
What's Trending in Skin Care: September 2022
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of September.
FDA Approves Dupliumab for Prurigo Nodularis
Sanofi and Regeneron’s dupliumab will provide relief to patients with extreme itch and skin lesions.
Pointers With Portela: Skin Conditions with PCOS
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses common skin conditions related to polycystic ovary syndrome.
FDA Clears CellFX System for the Treatment of Sebaceous Hyperplasia
Pulse Biosciences' new technology will treat sebaceous hyperplasia patients with Fitzpatrick skin types I-III.
Feds Warn of Monkeypox-Themed Malicious Email Campaign Targeting Health Care Providers
Don’t click on links or attachments unless you’re sure they are legitimate.
The Mainstream Patient: September 26
This week's edition of the Mainstream Patient features stories about the best sunscreens for fall, Botox for excessive sweating, Brad Pitt's entrance into the skin care industry, and more.
The Weekly Roundup: September 19-23
ICYMI, this week we had stories about the role of precision medicine for managing melanoma, a debridement drug for severe pediatric burns, roflumilast cream phase 3 results, and an exclusive KOL interview.
New Guidebook Offers Basics for Health Care Systems to Address Climate Change
Federal AHRQ offers starting point for reducing greenhouse gas emissions.
Select Skin Diseases are Higher in Patients with Inflammatory Bowel Disease
The occurrence of immune-mediated inflammatory diseases (IMID) is higher in patients with inflammatory bowel disease (IBD) than in the general population.
Pointers With Dr Portela: Laser Tattoo Removal
In this week’s Pointers with Dr Portela, the 208SkinDoc reviews a video of laser tattoo removal.
JAMA Publishes Roflumilast Cream Phase 3 Trial Results for Plaque Psoriasis
Arcutis Biotherapeutics’ roflumilast cream showed higher efficacy compared to vehicle in two phase 3 studies.
Maximize Profitability Minimize Errors
Billing Problems? CureMD Has You Covered.
EMA Accepts Application for Extended Indication of NexoBrid for Severe Pediatric Burns
MediWound’s debridement drug will provide a safer non-surgical alternative to severe thermal burns for pediatric patients.
Telemedicine Still Popular with Patients, but There are Concerns
Patients prefer virtual appointments for common ailments, but question the quality of care.
The Mainstream Patient: September 19
This week's edition of the Mainstream Patient features stories about skin cycling, skin care routines from dermatologists, upcoming nail trends, body care, and more.
The Weekly Roundup: September 12-16
ICYMI, this week we had stories about products to help manage acne, a case study on pediatric vitiligo, data results from a hidradenitis suppurativa clinical trial, BCC management, and more.
Will Kirby, DO, FAOCD, Talks With Karan Lal, DO, FAAD, MS
Will Kirby, DO, FAOCD, and Karan Lal, DO, FAAD, MS, talk about falling in love with medicine, the best dermatology advice ever received, and losing over 100 pounds.
New Device Offers Added Hope in Patients with Skin of Color
Aerolase launches the Exci308 to help fight common skin conditions.
The Mainstream Patient: September 12
This week's edition of the Mainstream Patient features stories about the best retinol creams, the Blue Beauty movement, lip blushing, and more.
Creating Diverse Teams Takes Work, But Is Worth the Effort
Organizations that focus on diversity, equity and inclusion are more productive and employees are more satisfied.
Are Women of Color Well Represented in Skin Aging Prevention Information?
At a poster session at the Skin of Color Update meeting in New York City, a study looked at whether women of color thought they were well-represented when it comes to learning about skin aging and prevention.
A Targeted Approach to Vitiligo Treatment
At the Skin of Color Update 2022 meeting, Pearl Grimes, MD, shares her thoughts on the recent approval of ruxolitinib cream.
Doctor Provides Overview on Assessing Vitiligo at EADV 2022
Medical experts use common set of criteria to diagnose disease.
Add an Outpatient Infusion Center to Your Dermatology Practice
Barbara McElroy, MSN, CRNI, VA-BC, discussed best practices for creating an infusion center at the National Infusion Center Association Annual Conference.
FDA Approves DaxibotulinumtoxinA for Injection for Glabellar Lines
DaxibotulinumtoxinA for Injection will provide long-lasting results with fewer injection treatments over time.
New Study Finds Skin Immune Biomarker Test Helps Predict Eczema in Babies
New sticky tape study can help predict onset of pediatric atopic eczema in babies.
Arcutis to Present Data Fom Topical Roflumilast Clinical Program at EADV 2022 Congress
Arcutis to present data from topical roflumilast clinical program at EADV 2022 Congress.
Consider Mental Health Concerns in Teens With Acne
The effect of acne is more than skin deep.
